This Week in Psychedelics

A weekly round-up of psychedelic news.

Plus: Barriers to vets seeking psychedelic-assisted therapy, and 2022 in review
Plus: Results from psychedelic brain imaging feasibility study and gaining clarity on perennial psychedelic research issues
Plus: Psilocybin and depression, Oregon, and Prince Harry
Plus: Quebec pays for psilocybin therapy, and Indigenous ethical principles to guide Western psychedelic research
Plus: Boom and busts of shroom stores and Health Canada releases guidance on psychedelic trials
Plus: DEA releases final 2023 drug quotas and Berkeley resolution could decriminalize psychedelics
Plus: Ayahuasca’s adverse effects, and new details on why the UK rejected Spravato
See all